Stanford researchers find blood test for Alzheimer's
Researchers at
The test shows promise in predicting which patients with mild memory loss are at high risk of developing the disease, which at this point can be diagnosed only by ruling out other possible causes.
The Stanford team, led by neuroscientist Tony Wyss-Coray, announced its findings in the newest issue of Nature Medicine. Its key findings: the identification of 18 distinctive proteins that appear with surprising consistency in the blood of Alzheimer's patients.
To do so, they screened out 120 such proteins that circulate in the blood and then created a test that lights up when the 18 biomarkers are present in a blood sample.
Though premature, the test's potential is garnering huge attention. In one experiment using stored blood samples, it proved positive for the disease in 38 out of 42 patients who had already been independently diagnosed.
Wyss-Coray is co-founder of Satoris Inc., a small company headquartered at the UCSF campus in
The company is working to bring two tests to the commercial market - one a diagnostic test for Alzheimer's disease, the second a test for mild cognitive impairment.
More than 5 million North Americans currently have Alzheimer's, and it is estimated that about 250,000 cases go undiagnosed every year. There is no definitive test for the disease until autopsy, when brain tissue is examined for the disease's characteristic protein plaques and tangles.
Silicon Valley /
http://www.bizjournals.com
Labels: 200710
